|
US7153827B1
(en)
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
|
US6734285B2
(en)
|
1994-03-08 |
2004-05-11 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 proteins and compositions
|
|
US7109308B1
(en)
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
|
US6040157A
(en)
*
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
CN1267550C
(en)
|
1994-03-08 |
2006-08-02 |
人体基因组科学有限公司 |
Vascular endothelial growth factor 2
|
|
US5932540A
(en)
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
|
US7727761B2
(en)
|
1995-08-01 |
2010-06-01 |
Vegenics Limited |
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
|
|
EP0848755B2
(en)
|
1995-09-08 |
2011-02-09 |
Genentech, Inc. |
Vegf-related protein
|
|
US7125714B2
(en)
|
1997-02-05 |
2006-10-24 |
Licentia Ltd. |
Progenitor cell materials and methods
|
|
AU3072099A
(en)
*
|
1998-03-13 |
1999-09-27 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
DE19813774A1
(en)
*
|
1998-03-27 |
1999-09-30 |
Max Planck Gesellschaft |
Parapox virus-encoded vascular endothelial cell growth factor (PPV-VEGF)
|
|
EP1121143A2
(en)
*
|
1998-03-27 |
2001-08-08 |
Dorothea J. Eicher |
Vegf and vegf-c as infant formula supplements
|
|
WO2000014105A1
(en)
|
1998-09-08 |
2000-03-16 |
Agouron Pharmaceuticals, Inc. |
Modifications of the vegf receptor-2 protein and methods of use
|
|
EP1568375A1
(en)
*
|
1998-10-26 |
2005-08-31 |
Ludwig Institute For Cancer Research |
Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
|
|
CN1338943A
(en)
*
|
1998-10-26 |
2002-03-06 |
路德维格癌症研究院 |
Use of VEGF-C or VEGF-D gene or protein to prevent resitenosis
|
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
|
DE69939484D1
(en)
|
1998-10-28 |
2008-10-16 |
Cornell Res Foundation Inc |
METHODS FOR REGULATING ANGIOGENESIS AND VASCULAR INTEGRITY BY TRK RECEPTOR LIGANDS BDNF, NT-3 AND NT-4
|
|
US6783953B1
(en)
|
1998-12-22 |
2004-08-31 |
Janssen Pharmaceutica N.V. |
Vascular endothelial growth factor-X
|
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
|
AU4643501A
(en)
*
|
2000-02-04 |
2001-08-14 |
Flanders Interuniversity Institute For Biotechnology (Vib) |
Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
|
|
US7727971B2
(en)
|
2000-02-04 |
2010-06-01 |
Life Sciences Research Partners Vzw |
Use of placental growth factor for treating ischemic muscle disease
|
|
AU2001255237B2
(en)
*
|
2000-04-06 |
2005-12-15 |
Wayne P. Franco |
Methods of using growth factors for treating heart disease
|
|
EP1157999A1
(en)
*
|
2000-05-24 |
2001-11-28 |
Introgene B.V. |
Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof
|
|
KR20020059609A
(en)
|
2000-08-04 |
2002-07-13 |
벤슨 로버트 에이치. |
Vascular endothelial growth factor 2
|
|
WO2002014367A1
(en)
*
|
2000-08-10 |
2002-02-21 |
Center For Advanced Science And Technology Incubation,Ltd. |
Chimeric human-type vascular endothelial cell growth factor
|
|
EP1191104A1
(en)
*
|
2000-09-26 |
2002-03-27 |
Introgene B.V. |
Gene delivery vehicles and use thereof in the preparation of a medicament and/or vaccine
|
|
CA2431308C
(en)
|
2000-12-07 |
2010-04-13 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
US7067317B2
(en)
|
2000-12-07 |
2006-06-27 |
Sangamo Biosciences, Inc. |
Regulation of angiogenesis with zinc finger proteins
|
|
DE60236646D1
(en)
|
2001-04-13 |
2010-07-22 |
Human Genome Sciences Inc |
Anti-VEGF-2 antibodies
|
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
CA2451311A1
(en)
*
|
2001-06-20 |
2003-01-03 |
Ludwig Institute For Cancer Research |
Stimulation of vascularization with vegf-b
|
|
CA2462374C
(en)
|
2001-10-15 |
2011-01-18 |
Janssen Pharmaceutica N.V. |
Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
|
|
EP1827494A4
(en)
*
|
2004-11-18 |
2010-02-17 |
Wayne Franco |
Combination growth therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US20120141424A1
(en)
*
|
2009-01-07 |
2012-06-07 |
Vegenics Pty Limited |
Materials and Methods for the Treatment of Hypertension
|
